UltraRapid Communication |
From the Feinberg Cardiovascular Research Institute (J.R., E.L., H.H., E.B., T.T., I.G., P.K., D.A., G.Q., D.W.L., R.K.), Feinberg School of Medicine, Northwestern University, Chicago, Ill; and Division of Neurology Research (K.M.R.) and Cardiovascular Research (Y.Z.), Caritas St. Elizabeths Medical Center. Tufts University School of Medicine, Boston, Mass.
Correspondence to Raj Kishore, PhD, Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave, Chicago IL 60611. E-mail r-kishore{at}northwestern.edu
The oocyte-independent source for the generation of pluripotent stem cells is among the ultimate goals in regenerative medicine. We report that on exposure to mouse embryonic stem cell (mESC) extracts, reversibly permeabilized NIH3T3 cells undergo dedifferentiation followed by stimulus-induced redifferentiation into multiple lineage cell types. Genome-wide expression profiling revealed significant differences between NIH3T3 control and ESC extract–treated NIH3T3 cells including the reactivation of ESC-specific transcripts. Epigenetically, ESC extracts induced CpG demethylation of Oct4 promoter, hyperacetylation of histones 3 and 4, and decreased lysine 9 (K-9) dimethylation of histone 3. In mouse models of surgically induced hindlimb ischemia or acute myocardial infarction transplantation of reprogrammed NIH3T3 cells significantly improved postinjury physiological functions and showed anatomic evidence of engraftment and transdifferentiation into skeletal muscle, endothelial cell, and cardiomyocytes. These data provide evidence for the generation of functional multipotent stem-like cells from terminally differentiated somatic cells without the introduction of retroviral mediated transgenes or ESC fusion.
Key Words: Somatic Cell Dedifferentiation ES cells Nuclear reprogramming Epigenetics Tissue Repair Myocardial infarction
This article has been cited by other articles:
![]() |
R. Kishore, P. Krishnamurthy, and D. W. Losordo Career Moves: Induced Pluripotent Cells From Human Aortic Smooth Muscle Cells Can Efficiently Redifferentiate Into Parental Phenotype Circ. Res., January 8, 2010; 106(1): 7 - 9. [Full Text] [PDF] |
||||
![]() |
D. P Sieveking and M. K. Ng Cell therapies for therapeutic angiogenesis: back to the bench Vascular Medicine, May 1, 2009; 14(2): 153 - 166. [Abstract] [PDF] |
||||
![]() |
F. Sotgia, F. Del Galdo, M. C. Casimiro, G. Bonuccelli, I. Mercier, D. Whitaker-Menezes, K. M. Daumer, J. Zhou, C. Wang, S. Katiyar, et al. Caveolin-1-/- Null Mammary Stromal Fibroblasts Share Characteristics with Human Breast Cancer-Associated Fibroblasts Am. J. Pathol., March 1, 2009; 174(3): 746 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Losordo and R. Kishore A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction. J. Am. Coll. Cardiol., January 6, 2009; 53(1): 10 - 12. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |